Skip to main content
. 2017 Dec 19;137(2):295–302. doi: 10.1007/s11060-017-2717-0

Table 1.

Characteristics of patients included in this study

Feature Grouping N or value %
Age Mean 53.9
Range 38–81
Histologic type Invasive ductal carcinoma 30 81.1
Others 4 10.8
Unknown 3 8.1
Histologic grade 1 1 2.7
2 8 21.6
3 20 54.1
Unknown 8 21.6
TNM stage 1 6 16.2
2 13 35.1
3 9 24.3
4 1 2.7
Unknown 8 21.6
ER status of primary tumor Positive 16 43.2
Negative 21 56.8
PR status of primary tumor Positive 13 35.1
Negative 24 64.9
HER2 status of primary tumor Positive 19 51.4
Negative 18 48.6
Primary breast cancer subtype HR+, HER2− 13 35.1
HR+, HER2+ 3 8.1
HR−, HER2+ 16 43.2
HR−, HER2− 5 13.5
Multiplicity Single brain metastasis 28 75.7
Multiple metastasis 9 24.3
Brain metastasis location Supratentorial 25 67.6
Infratentorial 8 21.6
Both 4 10.8

ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2, HR hormone receptor